Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognostic factors in a randomized multicenter clinical trial “DLBCL-2015”

Background. Diffuse large B-cell lymphoma (DLBCL) is one of the most common and aggressive tumors of the lymphatic system. Despite the frequency of occurrence, there is no single algorithm for treating DLBCL patients with poor prognostic factors. R-CHOP therapy does not allow achieving long-term com...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: M. O. Bagova, A. U. Magomedova, S. K. Kravchenko, Ya. K. Mangasarova, O. V. Margolin, E. S. Nesterova, L. G. Gorenkova, A. E. Misyurina, E. A. Fastova, F. E. Babaeva, K. A. Sychevskaya, S. M. Kulikov, Yu. A. Chabaeva, V. G. Savchenko
Formato: Artigo
Idioma:Russo
Publicado: ABV-press 2021-09-01
Series:Onkogematologiâ
Assuntos:
diffuse large b-cell lymphoma
toxicity
effectiveness
r-da-epoch
r-mnhl-bfm-90
Acceso en liña:https://oncohematology.abvpress.ru/ongm/article/view/491
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares